155 related articles for article (PubMed ID: 9711583)
41. Association of 5' CpG demethylation and altered chromatin structure in the promoter region with transcriptional activation of the multidrug resistance 1 gene in human cancer cells.
Kusaba H; Nakayama M; Harada T; Nomoto M; Kohno K; Kuwano M; Wada M
Eur J Biochem; 1999 Jun; 262(3):924-32. PubMed ID: 10411657
[TBL] [Abstract][Full Text] [Related]
42. Retroviral-mediated transfer and expression of the multidrug resistance protein 1 gene (MRP1) protect human hematopoietic cells from antineoplastic drugs.
Omori F; Juopperi T; Chan CK; Chang YN; Phipps S; Nanji S; Zhao Y; Stewart AK; Dubé ID
J Hematother Stem Cell Res; 1999 Oct; 8(5):503-14. PubMed ID: 10791901
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of P-glycoprotein expression and reversal of drug resistance of human hepatoma HepG2 cells by multidrug resistance gene (mdr1) antisense RNA.
Chan JY; Chu AC; Fung KP
Life Sci; 2000 Sep; 67(17):2117-24. PubMed ID: 11057761
[TBL] [Abstract][Full Text] [Related]
44. Arabidopsis MDR genes: molecular cloning and protein chemical aspects.
Dudler R; Sidler M
Methods Enzymol; 1998; 292():162-73. PubMed ID: 9711552
[No Abstract] [Full Text] [Related]
45. Mutational analysis of P-glycoprotein in yeast Saccharomyces cerevisiae.
Beaudet L; Gros P
Methods Enzymol; 1998; 292():414-27. PubMed ID: 9711571
[No Abstract] [Full Text] [Related]
46. IL-2 gene transfer for chemosensitization of multidrug-resistant human colon carcinoma cells.
Stein U; Walther W; Shoemaker RH; Schlag PM
Adv Exp Med Biol; 1998; 451():145-9. PubMed ID: 10026864
[No Abstract] [Full Text] [Related]
47. Functional expression of human P-glycoprotein from plasmids using vaccinia virus-bacteriophage T7 RNA polymerase system.
Hrycyna CA; Ramachandra M; Pastan I; Gottesman MM
Methods Enzymol; 1998; 292():456-73. PubMed ID: 9711574
[No Abstract] [Full Text] [Related]
48. Effects of several cytokine combinations on retrovirus-mediated human MDR1 gene transfer into bone marrow hematopoietic cells.
Zhou S; Tong Y; Tang PH; Mao N
Ann N Y Acad Sci; 1999 Apr; 872():391-4. PubMed ID: 10372142
[No Abstract] [Full Text] [Related]
49. Construction of a model cell line for the assay of MDR1 (multi drug resistance gene-1) substrates/inhibitors using HeLa cells.
Kugawa F; Suzuki T; Miyata M; Tomono K; Tamanoi F
Pharmazie; 2009 May; 64(5):296-300. PubMed ID: 19530439
[TBL] [Abstract][Full Text] [Related]
50. Characterization of the human multidrug resistance protein containing mutations in the ATP-binding cassette signature region.
Bakos E; Klein I; Welker E; Szabó K; Müller M; Sarkadi B; Váradi A
Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):777-83. PubMed ID: 9169612
[TBL] [Abstract][Full Text] [Related]
51. Antitumor effects of cytosine deaminase and thymidine kinase fusion suicide gene under the control of mdr1 promoter in mdr1 positive leukemia cells.
Wang X; Ji C; Ma D; Zhao J; Hou M; Yu H; Zang S
Leuk Lymphoma; 2007 Aug; 48(8):1600-9. PubMed ID: 17701592
[TBL] [Abstract][Full Text] [Related]
52. Generation of retroviral vector for clinical studies using transient transfection.
Yang S; Delgado R; King SR; Woffendin C; Barker CS; Yang ZY; Xu L; Nolan GP; Nabel GJ
Hum Gene Ther; 1999 Jan; 10(1):123-32. PubMed ID: 10022537
[TBL] [Abstract][Full Text] [Related]
53. PKC-independent modulation of multidrug resistance in cells with mutant (V185) but not wild-type (G185) P-glycoprotein by bryostatin 1.
Spitaler M; Utz I; Hilbe W; Hofmann J; Grunicke HH
Biochem Pharmacol; 1998 Oct; 56(7):861-9. PubMed ID: 9774148
[TBL] [Abstract][Full Text] [Related]
54. Efficient infection of a human T-cell line and of human primary peripheral blood leukocytes with a pseudotyped retrovirus vector.
Sharma S; Cantwell M; Kipps TJ; Friedmann T
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11842-7. PubMed ID: 8876225
[TBL] [Abstract][Full Text] [Related]
55. Expression of multidrug resistance associated transporters (MDR1, MRP1, LRP and BCRP) in porcine oocyte.
Takebayashi Y; Nakayama K; Fujioka T; Kanzaki A; Mutho M; Uchida T; Miyazaki K; Ito M; Fukumoto M
Int J Mol Med; 2001 Apr; 7(4):397-400. PubMed ID: 11254880
[TBL] [Abstract][Full Text] [Related]
56. Functional characterization of a glycine 185-to-valine substitution in human P-glycoprotein by using a vaccinia-based transient expression system.
Ramachandra M; Ambudkar SV; Gottesman MM; Pastan I; Hrycyna CA
Mol Biol Cell; 1996 Oct; 7(10):1485-98. PubMed ID: 8898356
[TBL] [Abstract][Full Text] [Related]
57. Retroviral coexpression of two different types of drug resistance genes to protect normal cells from combination chemotherapy.
Suzuki M; Sugimoto Y; Tsukahara S; Okochi E; Gottesman MM; Tsuruo T
Clin Cancer Res; 1997 Jun; 3(6):947-54. PubMed ID: 9815770
[TBL] [Abstract][Full Text] [Related]
58. Construction and application of double-transfected cells expressing the human transporter P-glycoprotein and cytochrome P450 3A4.
Hu HH; Su C; Jiang Y; Yu LS; Liu Y; Tian Y; Xu SY; Zhou H; He X; Jiang HD; Zeng S
Pharmazie; 2013 Oct; 68(10):816-20. PubMed ID: 24273886
[TBL] [Abstract][Full Text] [Related]
59. Yeast secretory vesicle system for expression and functional characterization of P-glycoproteins.
Ruetz S
Methods Enzymol; 1998; 292():382-96. PubMed ID: 9711569
[No Abstract] [Full Text] [Related]
60. Physical mapping of a tandem duplication on the long arm of chromosome 7 associated with a multidrug resistant phenotype.
de Silva MG; Kantharidis P; Scherer SW; Rayeroux K; Campbell L; Tsui LC; Zalcberg JR
Cancer Genet Cytogenet; 1999 Apr; 110(1):28-33. PubMed ID: 10198619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]